Earnings
Home›Earnings›Results›Concentra Q2 revenue and profit beat estimates, liftin…
Concentra Q2 revenue and profit beat estimates, lifting shares
Revenue rose 10% year over year to $606 million, and adjusted EPS reached 52 cents versus 42 cents expected.
Concentra reported Q2 results that topped Wall Street expectations, with the company recording 10% year over year revenue growth to $606 million, above analysts’ $592 million projection, according to MarketBeat Ratings.
Adjusted earnings per share came in at 52 cents, ahead of the 42 cents analysts expected, the outlet added, citing the company’s Aug. 6 second-quarter report.
MarketBeat Ratings also noted that Concentra’s stock has risen sharply since Select Medical spun it off in 2024, while the article flagged ongoing questions about valuation following the rally.
The outlet said eight analysts rate Concentra a Buy, but investors face a key decision on whether the occupational health provider can keep justifying a higher price after the recent run.